Secondary Logo

Journal Logo

Brief Reports

Association of White Blood Cell Count and C-Reactive Protein with Outcomes in Children Hospitalized for Community-acquired Pneumonia

Williams, Derek J. MD, MPH*; Hall, Matthew PhD; Auger, Katherine A. MD; Tieder, Joel S. MD, MPH§; Jerardi, Karen E. MD, MEd; Queen, Mary Ann MD; Statile, Angela M. MD, MEd; Myers, Angela L. MD, MPH; Shah, Samir S. MD, MSCE

Author Information
The Pediatric Infectious Disease Journal: July 2015 - Volume 34 - Issue 7 - p 792-793
doi: 10.1097/INF.0000000000000724


Peripheral white blood cell (WBC) count and C-reactive protein (CRP) are obtained frequently among children hospitalized with pneumonia.1 A number of prior studies indicate poor sensitivity and specificity for differentiating bacterial from viral etiologies for both tests, suggesting little utility for informing antibiotic treatment decisions.2–9 However, the potential role of WBC count and CRP for predicting disease course and clinical outcomes remains undetermined. Several adult pneumonia studies indicate that CRP values may be useful for predicting clinical outcomes,10,11 whereas others suggest little value of such testing.12 Similar studies have not been conducted in children. Therefore, we sought to determine the association between peripheral WBC count and CRP values with pneumonia outcomes, including fever duration and hospital length of stay (LOS).


This study was nested within a multicenter, retrospective cohort of children assembled to validate International Classification of Diseases, 9th revision, Clinical Modification discharge diagnosis codes for community-acquired pneumonia.13 In that study, we identified 676 children 2 months to <18 years of age hospitalized between January 1, 2010 and December 31, 2010 at 1 of 4 free-standing children’s hospitals with provider-confirmed community-acquired pneumonia by medical record review as described previously. The main exposures in this study were CRP (mg/dL) and WBC count (×103 per mm3), and only children from the validation study with both tests performed within 24 hours of admission were included (n = 153; 22.6%). Outcomes included duration of fever and hospital LOS, both measured in hours. Duration of fever was measured as the time from emergency department arrival until the last recorded temperature >38.0°C (measured per clinical routine, ie, no less than every 8 hours). Additional data collected included patient demographics (age, sex, race/ethnicity and payor), presence of a complex chronic condition,14 presence and size (small or moderate/large) of pleural effusion and admission to intensive care or need for invasive mechanical ventilation within the first 2 calendar days of admission. The institutional review board at each hospital approved the study.

Data were summarized using frequency (%) for categorical variables and median (interquartile range, IQR) values for continuous variables. Associations between the main exposures (WBC count and CRP) and outcomes (duration of fever and hospital LOS) were modeled using multivariable linear regression with an exponential distribution. Models were adjusted for hospital clustering with a random intercept for each hospital. Final models were constructed using backward elimination that initially included all covariates described above; a priori, the main exposures and age were included regardless of statistical significance. Results are presented as ratios of means with associated 95% confidence intervals. To aid in clinical interpretability of the results, we also modeled the log of LOS using a linear mixed effects model clustered on hospital and back transformed the parameter estimates. All analyses were performed using SAS v.9.3 (SAS Institute, Cary, NC). A 2-sided P value <0.05 was considered significant for all analyses.


The majority of the 153 included children were young (61.4% <6 years; see Table, Supplemental Digital Content 1, Twelve children (7.8%) had a complex chronic condition. Nineteen children (12.4%) were admitted to the intensive care unit, and 11 (7.2%) required invasive mechanical ventilation within the first 2 calendar days of admission. The median peripheral WBC count was 14.4 × 103 per mm3 (IQR: 9.5, 20.1), and the median CRP was 7.5 mg/dL (IQR: 2.5, 19.6). Fever resolved within 24 hours of admission for 103 children (67.3%) and within 48 hours of admission for 117 children (76.5%). None of the included children had fever documented within 6 hours of discharge. The median hospital LOS was 66 hours (IQR: 44, 134 hours). There were no deaths.

In addition to the main exposures and age (selected a priori), only mechanical ventilation was retained in the final multivariable models, demonstrating a strong association with both hospital LOS and fever duration (Table 1). Similarly, increasing CRP was associated with increased fever duration (adjusted ratio of means 1.08; 95% CI: 1.05–1.10) and increased LOS (adjusted ratio of means 1.03; 95% CI: 1.00–1.04). From the secondary LOS analysis using multivariable linear regression, we conclude that for every 1 mg/dL increase in CRP, LOS is expected to increase by 1 hour (see Table, Supplemental Digital Content 2, In contrast, neither age nor peripheral WBC count was associated with either outcome.

Association of CRP and Peripheral WBC Count with LOS and Duration of Fever for Children Hospitalized with Pneumonia


In this multicenter study of children hospitalized with community-acquired pneumonia, CRP measured within 24 hours of hospital admission was associated with both hospital LOS and fever duration. Baseline peripheral WBC count was not independently associated with either outcome.

Among adults with pneumonia, CRP alone demonstrated good discrimination for predicting hospitalization (area under the curve 0.73)10 but predicted mortality less well (area under the curve 0.62).12 The addition of CRP to validated severity scores led to modest improvements in both the ability to predict hospitalization10 and mortality.11 Our results indicate that CRP, measured at the time of admission, may also prove useful for predicting outcomes among children hospitalized with pneumonia. As such, CRP should be considered for inclusion in the development of pediatric pneumonia severity scores. Our findings also support the 2011 Pediatric Infectious Diseases Society/Infectious Diseases Society of America guidelines for the management of community-acquired pneumonia in children, which recommend consideration of acute-phase reactants such as CRP for those with severe disease.15

The 2011 Pediatric Infectious Diseases Society/Infectious Diseases Society of America guidelines do not recommend routine performance of complete blood counts; instead, the guidelines recommend that complete blood counts be reserved only for those children with severe pneumonia.15 For this population, the committee noted the importance of screening for significant anemia or thrombocytopenia, which may herald more serious complications. In contrast, the committee emphasized the lack of predictive ability of WBC count for distinguishing bacterial from viral etiologies. Although our study did not examine etiology, our findings further highlight the poor utility of WBC count by failing to demonstrate an association between WBC count and disease outcomes. Thus, although complete blood counts may help identify complications in those with severe pneumonia, reliance on the WBC count to help guide management decisions should be discouraged.

Our study has several limitations, largely related to the retrospective observational design. Only a fraction of children in the larger validation study with provider-confirmed pneumonia had both CRP and WBC count measured during the first 24 hours of admission (see Table, Supplemental Digital Content 1, It is likely that our study represents a more severe population and may not be directly generalizable to a nonselective population of children hospitalized with pneumonia. Although a number of covariates were considered for inclusion in the multivariable models, there is potential for residual confounding because of unmeasured factors. Finally, although low WBC count may also portend worse outcomes, the paucity of children with leukopenia in this cohort (n = 6) precluded meaningful subanalysis. Given these limitations, it will be important to confirm our findings in future prospective studies.


1. Brogan TV, Hall M, Williams DJ, et al. Variability in processes of care and outcomes among children hospitalized with community-acquired pneumonia. Pediatr Infect Dis J. 2012;31:1036–1041
2. Furer V, Raveh D, Picard E, et al. Absence of leukocytosis in bacteraemic pneumococcal pneumonia. Prim Care Respir J. 2011;20:276–281
3. Esposito S, Bosis S, Cavagna R, et al. Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2–5 years of age with community-acquired pneumonia. Clin Infect Dis. 2002;35:1345–1352
4. Toikka P, Irjala K, Juvén T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J. 2000;19:598–602
5. Cevey-Macherel M, Galetto-Lacour A, Gervaix A, et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr. 2009;168:1429–1436
6. Juvén T, Mertsola J, Toikka P, et al. Clinical profile of serologically diagnosed pneumococcal pneumonia. Pediatr Infect Dis J. 2001;20:1028–1033
7. Flood RG, Badik J, Aronoff SC.. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children. Pediatr Infect Dis J. 2008;27:95–99
8. Virkki R, Juven T, Rikalainen H, et al. Differentiation of bacterial and viral pneumonia in children. Thorax. 2002;57:438–441
9. Heiskanen-Kosma T, Korppi M.. Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings. Scand J Infect Dis. 2000;32:399–402
10. España PP, Capelastegui A, Bilbao A, et al.Population Study of Pneumonia (PSoP) Group. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 2012;31:3397–3405
11. Menéndez R, Martínez R, Reyes S, et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax. 2009;64:587–591
12. Krüger S, Ewig S, Marre R, et al.CAPNETZ Study Group. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J. 2008;31:349–355
13. Williams DJ, Shah SS, Myers A, et al. Identifying pediatric community-acquired pneumonia hospitalizations: accuracy of administrative billing codes. JAMA Pediatr. 2013;167:851–858
14. Feudtner C, Hays RM, Haynes G, et al. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics. 2001;107:E99
15. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25–e76

pneumonia; outcomes; pediatrics; C-reactive protein; white blood cell count

Supplemental Digital Content

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.